SLD 0.42 ▲0.00% MBG 0.21 ▲0.00% FDC 3.93 ▼-0.76% LF1 1.87 ▼-2.12% LGF 2.38 ▲0.86% DN1 98.00 ▼-0.17% WMX 1.58 ▼-2.46% RG8 2.52 ▲0.40% CTS 0.89 ▲2.89% TET 0.42 ▲1.20% MRE 1.68 ▲0.00% BST 0.27 ▲3.85% EFR 0.01 ▲0.00% RIV 1.20 ▼-0.42% KIT 1.80 ▲0.56% EMUCA 0.89 RF1 3.38 ▲0.00% AIX 9.00 ▲0.22% SLD 0.42 ▲0.00% MBG 0.21 ▲0.00% FDC 3.93 ▼-0.76% LF1 1.87 ▼-2.12% LGF 2.38 ▲0.86% DN1 98.00 ▼-0.17% WMX 1.58 ▼-2.46% RG8 2.52 ▲0.40% CTS 0.89 ▲2.89% TET 0.42 ▲1.20% MRE 1.68 ▲0.00% BST 0.27 ▲3.85% EFR 0.01 ▲0.00% RIV 1.20 ▼-0.42% KIT 1.80 ▲0.56% EMUCA 0.89 RF1 3.38 ▲0.00% AIX 9.00 ▲0.22%

EBO EBOS Group Limited

Healthcare · Medical Distribution · website · 5,009 employees
$15.14
52wk 15.00 – 26.71
Overall
45.0
Value
69.1
Growth
60.3
Health
39.7
Quality
24.7
Momentum
0.3
Dividend
74.3
Price
About EBOS Group Limited

EBOS Group Limited engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, and animal care products in Australia, Southeast Asia, and New Zealand. It operates through the Healthcare and Animal Care segments. The company provides healthcare logistics; medication management solutions; pharmacy management software; pharmacy data, consumer loyalty, and analytics services; and health communications, programs, and consultancy services. It also offers community-based health care services and programs; vitamins, minerals and supplements, herbal and fruit teas, and natural toothpastes, as well as functional foods, including molasses and manuka honey; Pharmacy Choice, a five-step integrated retail program for independent pharmacies; and healthSAVE, a community pharmacy banner that helps members drive their retail businesses. In addition, the company offers healthcare distribution, warehousing, clinical trial management, and product registration services; clinical trial logistics; aesthetic healthcare devices, medical-grade cosmeceuticals, and injectables; dog and cat food, and treats; and surgical devices and medical consumables. Further, it provides pet nutrition, treats, clean-up, and grooming products and accessories; supplies pet medicines and other products to veterinary clinics and specialty retailers; manufactures and supplies dog rolls; and wholesales veterinary products. The company was formerly known as Early Bros Dental & Surgical Supplies Ltd. and changed its name to EBOS Group Limited in 1986. EBOS Group Limited was incorporated in 1922 and is headquartered in Docklands, Australia.

Price analytics

Returns

1 day -1.9%
1 week -2.8%
1 month -10.0%
3 months -15.0%
6 months -19.7%
1 year -41.9%
3 years -53.0%

Risk

Volatility (1y ann.) 27.2%
Beta vs ASX 200 0.41
Sharpe (1y) -2.00
VaR 95% (1-day) -3.1%
Max drawdown (1y) -41.7%
Off 1-year high -41.7%

Technicals

RSI(14) 17 OS
vs 50DMA -12.5%
vs 200DMA -19.1%
Trend Death cross
Fundamental trends
Financial statements
Loading…
Scoring breakdown (2 Oct 2026)
Value 69.1
Trailing P/E
81
Forward P/E
87
PEG ratio
0
EV / EBITDA
61
Price / Book
95
Price / Sales
100
Growth 60.3
Revenue growth (1y)
98
Revenue CAGR (3y)
49
EPS growth (1y)
66
EPS CAGR (3y)
20
Financial Health 39.7
Net debt / EBITDA
28
Interest coverage (EBIT/interest)
32
Current ratio
21
Debt / Equity
72
Quality (Profitability & Cash Flow) 24.7
Return on equity
42
Return on assets
31
Operating margin
11
Net margin
11
Cash conversion (OCF / net income)
—
Dividend / Income 74.3
Dividend yield (%)
93
Payout ratio
52
FCF dividend cover
80
Momentum 0.3
6-month return vs ASX 200
0
Price vs 200-day average
0
Price vs 50-day average
0
Position in 52-week range
1

Hover a row's info icon for the exact rule. Bounds and weights are configurable in the Django admin (Scoring configuration).

Score history
Key metrics
Market cap
$3.13B
P/E (trailing)
14.02
P/E (forward)
11.58
EPS (trailing)
1.08
Dividend yield
5.7%
Payout ratio
78.7%
Beta
0.15
EV / EBITDA
10.15
Price / Book
1.14
ROE
8.3%
Operating margin
2.9%
Net margin
1.7%
Total cash
$252.51M
Total debt
$1.90B
Current ratio
1.16
Debt / Equity
0.70
Free cash flow
$137.69M
Avg volume
113,736
Latest annual results (FY ending 30 Jun 2026)
  • Revenue$16.41B
  • Gross profit$2.12B
  • Operating income$458.93M
  • Net income$273.95M
  • Diluted EPS1.33
  • Free cash flow$336.09M
  • Net debt$2.02B
Sector peers (Healthcare)
TickerMkt cap P/EScore
CSL $84.15B — 54.3
RMD $45.86B 21.2 74.4
SIG $29.91B 43.3 55.6
FPH $21.64B 57.5 71.1
PME $16.34B 61.8 69.0
RHC $12.56B 40.0 40.2
SHL $9.12B 15.0 43.0
COH $8.20B 55.5 39.4